| http://www.w3.org/ns/prov#value | - ctor of any bleeding episodes [see Warnings and Precautions (5.4)].17.4 Cardiac FailureAdvise patients that cardiac failure may develop during INLYTA treatment and that signs or symptoms of cardiac failure should be regularly monitored for during treatment [see Warnings and Precautions (5.5)]. 17.5 Gastrointestinal DisordersAdvise patients that gastrointestinal disorders such as diarrhea, nausea,
|
